| 000 | 01749 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516144830.0 | ||
| 264 | 0 | _c20130802 | |
| 008 | 201308s 0 0 fre d | ||
| 022 | _a1769-6658 | ||
| 024 | 7 |
_a10.1016/j.canrad.2013.02.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPommier, P | |
| 245 | 0 | 0 |
_a[Valorisation of brachytherapy and medico-economic considerations]. _h[electronic resource] |
| 260 |
_bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _cApr 2013 |
||
| 300 |
_a178-81 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 |
_aBrachytherapy _xadverse effects |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 |
_aGenital Neoplasms, Female _xeconomics |
| 650 | 0 | 4 |
_aGlobal Health _xeconomics |
| 650 | 0 | 4 | _aHealth Expenditures |
| 650 | 0 | 4 |
_aHospitalization _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xeconomics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNational Health Programs |
| 650 | 0 | 4 |
_aNeoplasms _xeconomics |
| 650 | 0 | 4 |
_aProstatectomy _xeconomics |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xeconomics |
| 650 | 0 | 4 |
_aRadiation Injuries _xeconomics |
| 650 | 0 | 4 |
_aRadiometry _xeconomics |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xeconomics |
| 700 | 1 | _aMorelle, M | |
| 700 | 1 | _aMillet-Lagarde, F | |
| 700 | 1 | _aPeiffert, D | |
| 700 | 1 | _aGomez, F | |
| 700 | 1 | _aPerrier, L | |
| 773 | 0 |
_tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _gvol. 17 _gno. 2 _gp. 178-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canrad.2013.02.004 _zAvailable from publisher's website |
| 999 |
_c22683944 _d22683944 |
||